A Path Analysis of Effects of Patients’ Underlying Conditions, Treatment Satisfaction, and Adherence on Quality of Life Among Korea Glaucoma Patients

Supplemental Digital Content is available in the text. Précis: This observed patient-specific features and treatment-driven conditions that were significantly associated with the impairment of health-related quality of life (HRQOL) among glaucoma patients. The results suggest that more systematic strategies should be implemented to improve an HRQOL. Purpose: To determine factors contributing to an HRQOL and assess total, direct and indirect, effects that may exist between the determinants using path analysis. Materials and Methods: Data were derived from previous Korea glaucoma outcomes research. A total of 847 glaucoma outpatients with ≤2 years of eye-drop use were included in the present study. Including factors and their hypothetical pathways to an HRQOL were based on the literature review and consultation with specialists. Age, sex, comorbidities, and education levels were included as underlying conditions and treatment patterns were defined by the number of daily instillations of prescribed eye-drops. Treatment satisfaction and adherence were estimated using a Treatment Satisfaction Questionnaire for Medication, which assessed side-effects, effectiveness, convenience, global satisfaction, and pill count. An HRQOL was assessed by EQ-5D and EQ-visual analogue scale (EQ-VAS). Results: In EQ-5D analysis, male individuals showed total effects (β=0.102, P=0.0026), including both direct (β=0.076, P=0.0095) and indirect effects (β=0.0253, P=0.0020), which were mediated by treatment satisfaction in the side effects and global satisfaction categories. Higher education (β=0.197, P=0.0020) and satisfaction in the side effect (β=0.095, P=0.0076) and global satisfaction (β=0.075, P=0.0414) categories were found to have direct effects on EQ-5D. For EQ-VAS, higher education levels had significant total effects (β=0.153, P=0.0020) accounting for direct effects (β=0.131, P=0.0030) and indirect effects (β=0.0223, P=0.0531) through global satisfaction. In addition, male individuals had indirect effects (β=0.274, P=0.0165), which was indirectly mediated by satisfaction in the global satisfaction category. Comorbidity (β=−0.096, P=0.0090) and satisfaction in the effectiveness (β=0.094, P=0.0302), convenience (β=0.076, P=0.0390), and global satisfaction (β =0.144, P=0.0020) categories showed indirect effect on EQ-VAS. Conclusion: Higher education and better treatment satisfaction had positive effects on HRQOL both in direct and indirect ways whereas comorbidities indirectly showed negative associations with HRQOL.

[1]  V. Petrosyan,et al.  Factors associated with vision-related quality of life among the adult population living in Nagorno Karabagh. , 2017, Public health.

[2]  P. Rasmussen,et al.  The impact of quality of life on treatment preferences in multiple sclerosis patients , 2017, Patient preference and adherence.

[3]  Y. Ko,et al.  Impact of socioeconomic status on vision-related quality of life in primary open-angle glaucoma , 2017, Eye.

[4]  Yong Yeon Kim,et al.  Treatment patterns and medication adherence of patients with glaucoma in South Korea , 2017, British Journal of Ophthalmology.

[5]  L. Calvó-Perxas,et al.  A Path Analysis of Dependence and Quality of Life in Alzheimer’s Disease , 2017, American journal of Alzheimer's disease and other dementias.

[6]  C. Koutras,et al.  ADHERENCE AND QUALITY OF LIFE IN PATIENTS WITH TYPE II DIABETES MELLITUS IN NORTHERN GREECE , 2016, Materia socio-medica.

[7]  Akitaka Tsujikawa,et al.  The Relationship Between Vision-related Quality of Life and Visual Function in Glaucoma Patients , 2016, Journal of glaucoma.

[8]  Hakan Tüzün,et al.  IMPACT OF COMORBIDITY AND SOCIOECONOMIC STATUS ON QUALITY OF LIFE IN PATIENTS WITH CHRONIC DISEASES WHO ATTEND PRIMARY HEALTH CARE CENTRES. , 2015, Central European journal of public health.

[9]  Caroline A. Baan,et al.  The impact of comorbid chronic conditions on quality of life in type 2 diabetes patients , 2015, Quality of Life Research.

[10]  W. Krijnen,et al.  Relationship between socioeconomic status and quality of life in older adults: a path analysis , 2015, Quality of Life Research.

[11]  Hylton B. Menz,et al.  Determinants of health-related quality of life in people with Parkinson’s disease: a path analysis , 2013, Quality of Life Research.

[12]  S. Ko,et al.  A catalogue of EQ-5D utility weights for chronic diseases among noninstitutionalized community residents in Korea. , 2009, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[13]  B. Brorsson,et al.  Quality of life among patients with glaucoma in Sweden. , 2009, Acta ophthalmologica Scandinavica.

[14]  V. Martínez-Vizcaíno,et al.  Visual impairment and quality of life: gender differences in the elderly in Cuenca, Spain , 2008, Quality of Life Research.

[15]  H. Quigley,et al.  The number of people with glaucoma worldwide in 2010 and 2020 , 2006, British Journal of Ophthalmology.

[16]  T. Kershaw,et al.  Coping strategies and quality of life in women with advanced breast cancer and their family caregivers , 2004 .

[17]  X. Badia,et al.  Acromegaly Quality of Life Questionnaire (AcroQoL) , 2004, Health and quality of life outcomes.

[18]  M. Atkinson,et al.  Health and Quality of Life Outcomes , 2004 .

[19]  R. P. Mills,et al.  The Collaborative Initial Glaucoma Treatment Study: interim quality of life findings after initial medical or surgical treatment of glaucoma. , 2001, Ophthalmology.

[20]  A. Coleman,et al.  Functional status and well-being in patients with glaucoma as measured by the Medical Outcomes Study Short Form-36 questionnaire. , 1998, Ophthalmology.

[21]  M. Meltzer,et al.  Glaucoma's impact on quality of life and its relation to clinical indicators. A pilot study. , 1998, Ophthalmology (Rochester, Minn.).

[22]  Chris A. Johnson,et al.  Influence of glaucomatous visual field loss on health-related quality of life. , 1997, Archives of ophthalmology.

[23]  R. Parrish,et al.  Visual impairment, visual functioning, and quality of life assessments in patients with glaucoma. , 1997, Transactions of the American Ophthalmological Society.

[24]  H. Quigley Number of people with glaucoma worldwide. , 1996, The British journal of ophthalmology.

[25]  J. Chudek,et al.  Comorbidities and the quality of life in hypertensive patients. , 2012, Polskie Archiwum Medycyny Wewnetrznej.

[26]  D. Cucinotta,et al.  Clinical and socio-economic correlates of quality of life and treatment satisfaction in patients with type 2 diabetes. , 2009, Nutrition, metabolism, and cardiovascular diseases : NMCD.